UPDATE I-STOP and E-Prescribing
|
|
|
- Benjamin Hunt
- 9 years ago
- Views:
Transcription
1 UPDATE I-STOP and E-Prescribing Tracy Russell PSSNY Executive Director
2 Learning Objectives State the statistics regarding the success of the I-Stop regulations Define electronic prescribing in NYS regulations Identify the timeline for electronic prescribing Describe the requirements for the practitioner Describe the pharmacy application requirements List the requirements for the DEA Take Back Program
3 Prescription Drug Reform Act I-STOP Internet System to Track Over-Prescribing 3
4 Prescription Drug Reform Act (more commonly known as I-STOP) Part A: I-STOP August 27, 2013 Part B: Electronic Prescribing March 27, 2015 Part C: Part D: Part E: Controlled Substance Schedule Changes 3309 Work Group Safe Disposal Program 4
5 Bureau of Narcotic Enforcement Narcotic Investigations Conducts investigations, inspections, outreach; Partners with law enforcement and regulatory agencies. Regulatory Compliance Issues licenses, certifications, and permits. Public Health Initiatives & Administration Administers Official Prescription Program, Prescription Monitoring Program, and grants; Conducts education and outreach; Helps formulate policy and regulations. 5
6 Prescription Drug Reform Act (more commonly known as I-STOP) Part A: I-STOP August 27, 2013 Part B: Electronic Prescribing March 27, 2015 Part C: Part D: Controlled Substance Schedule Changes 3309 Work Group Part E: Safe Disposal Program 6
7 Safe Disposal Program DEA Take Back
8 8
9 Safe Disposal Consumers need a means to safely dispose of prescription medications including controlled substances Safe disposal sites established with local police departments New law in NY Article 33, Section 3343-b Important to note disposal must be in accordance with federal law. Federal rules yet to be finalized 9
10 Medication Drop Box Map Drop Box Available Drop Box Not Available 10
11
12 Prescription Drug Reform Act (more commonly known as I-STOP) Part A: I-STOP August 27, 2013 Part B: Electronic Prescribing March 27, 2015 Part C: Part D: Part E: Controlled Substance Schedule Changes 3309 Work Group Safe Disposal Program 12
13 Access to PMP Data Prescribers (excluding Veterinarians) Pharmacists Attorney General s Office County Health Departments engaged in public health research or education Medical Examiner/Coroners Patients 13
14 Designees for Pharmacists Limited to other pharmacists and pharmacy interns Each designee must establish their own HCS Account After the designee obtains an HCS account user ID, the pharmacist will need to log into the HCS, open the PMP application, and click on the Designation tab. On the designation screen, the pharmacist will enter the HCS user ID of the individual that will be performing the look up on their behalf as a designee.
15 PMP Searches by Profession 8/27/13 4/13/14 8% 8% 3% 12% 69% Medicine Nurse Practitioners Pharmacist 15
16 PMP Data Submission After receiving these records, BNE Screens all records for critical errors; Rejects any record containing a critical error and notifies the submitter so it can be corrected; De-duplicates any identical records; Matches new record to existing patient records; Presents new record in PMP Registry This process takes about 2 hours from when BNE receives the original record. 16
17 PMP Data Submission Effective August 27, 2013, pharmacies were required to submit controlled substance prescription data to BNE within 24 hours via the PMP. October 1, 2014, pharmacies are required to submit controlled substance prescription data to BNE using ASAP 4.2 According to BNE 68% records are currently being submitted in % of the submitters are using % of the dispensers are using
18 Prescription Drug Reform Act I-STOP Internet System to Track Over-Prescribing Software Application Update 18
19 Changes related to the ASAP 4.2 submission requirements effective October 1, 2014 Field Name Data Element Edit Effective October 1, 2014 Date Sold DSP17 This field will be required. This field is used to capture the date the controlled substance left the pharmacy (delivery to the patient, not the date it was filled, if the dates differ). Date Filled (DSP05) will continue to be a required data element. If the prescription is filled and delivered to the patient on the same day, the Date Sold and Date Filled fields will contain the same date. An error will result if the field is empty, null or submitted with all zeroes. The date must be a valid date between date written and current date in the following format; CCYYMMDD. Species Code PAT20 This field will be required. This field is used to differentiate a prescription for a human being from one prescribed for an animal. An error will result if the field is empty or null. This field must be submitted with a value of 01 (Human) or 02 (Veterinary) Name of Animal PAT23 This field will be required if PAT20 = 02 (Veterinary Patient). Alphanumeric characters and may contain, and. DEA Number Suffix PRE03 A warning will be generated if this field is left blank or null and the DEA Number field (PRE02) contains an institutional DEA number. This is not a required field for data submission.
20 All pharmacies accepting E-Prescriptions for Controlled substances must report the following data elements using the ASAP 4.2 standard Field Name Electronic Prescription Reference Number Data Element DSP20 Description of Edit This field is required if AIR01 = NY and AIR02 = eeeeeeee (electronic prescription). The value must be alphanumeric. Electronic Prescription Order Number DSP21 This field is required if AIR01 = NY and AIR02 = eeeeeeee (electronic prescription). The value must be alphanumeric.
21 PMP Resources Bureau of Narcotic Enforcement Contact information Riverview Center Regional Offices: 150 Broadway, Albany, NY NYC: (212) (866) Buffalo: (716) Syracuse: (315) Rochester: (585)
22 22
23 Prescription Drug Reform Act (more commonly known as I-STOP) Part A: I-STOP August 27, 2013 Part B: Electronic Prescribing March 27, 2015 Part C: Part D: Part E: Controlled Substance Schedule Changes 3309 Work Group Safe Disposal Program 23
24 Electronic Prescribing of Controlled Substance (ECPS)
25 Electronic Prescribing Effective June 1, 2010 Federal ruling, DEA allows for electronic prescribing of controlled substances Effective March 27, NYS Regulations allows for electronic prescribing of controlled substances (EPCS). Effective March 27, Electronic prescribing of controlled and non-controlled substances becomes mandatory for all prescribers. 25
26 Regulations Federal Rule Electronic Prescriptions for Controlled Substances 10 NYCRR Part 80 Rules Click on the link to New York State Regulations related to Electronic Prescribing of Controlled Substances 26
27 Why Electronic Prescribing? Next step in medical technology Curtail forged and counterfeit prescriptions Reduce medication errors associated with bad handwriting Will eventually allow for interstate communication to potentially reduce prescription theft and forgery 27
28 What is Electronic Prescribing? Authorizes a practitioner to issue an electronic prescription in Schedules II-V Requires a pharmacist to annotate, dispense, endorse and electronically archive electronic prescriptions for controlled substances Electronic Prescription defined as A prescription issued with an electronic signature and transmitted by electronic means in accordance with regulations of the commissioner and the commissioner of education and consistent with federal requirements. "Electronic" is defined as - means of or relating to technology having electrical, digital, magnetic, wireless, optical, electromagnetic or similar capabilities. 28
29 NYS Regulations for Computer Applications Requires all prescribers and pharmacists engaging in electronic prescribing and dispensing of controlled substances to utilize computer applications that meet federal security requirements All computer applications must be registered with the NYS DOH/BNE All computer applications must be certified by the DEA 29
30 Must be capable of retrieving controlled substance prescriptions by practitioner name, patient name, drug name, date filled and date dispensed Must allow downloading of prescription data into a database or spreadsheet that is readable and sortable Must maintain an audit trail of a number of actions (e.g., receipt annotation, alteration, changes in logical access) Must conduct internal audits and protect records Retain archived records electronically 30
31 Registering Certified Application with BNE Current Process contact BNE, forms to be completed will be sent Upcoming Forms will be available online Ultimately online registration process BNE Website - Once Registration Form is Received About one week to process Registrant will receive an advising that application has been registered with NYS 31
32 32
33 How do I know my software vendor has met the requirements? Do NOT call BNE Ask your software vendor representative Check the Surescripts website Products and Services/Pharmacy/EPCS/Certified Software Vendors and Pharmacies 33
34 BNE doesn t have all the information on software/logical access that would verify if an application is in compliance with the federal rule. We are aware of different vendors that have different types of software or applications and not only are we not allowed to comment on this we cannot verify whether a particular software or version is compliant or not. The best recommendation is to advise pharmacists/pharmacies to contact the vendors directly and ask. Pharmacies may have different needs for software. First inquiry be to your existing pharmacy software vendor and then just as a business would choose other types of software, evaluate what is out there that meets their needs and meets the federal requirements.
35 How do I know my software vendor has met the requirements? Do NOT call BNE Ask your software vendor representative Check the Surescripts website Products and Software Vendors and Pharmacies Services/Pharmacy/EPCS/Certified 35
36
37
38
39
40 Electronic Prescribing of Controlled Substance (ECPS) Prescriber Responsibilities
41 EPCS Transmission EPCS application must transmit the electronic prescription as soon as possible after signature by the practitioner Electronic prescription may be printed only if practitioner has been notified of transmission failure Printed version must contain information relating to original electronic transmission failure 41
42 EPCS Transmission Copies of EPCS transmitted prescription must state Copy only not valid for dispensing. EPCS application must not allow for electronic transmission if original was printed prior to electronic transmission At no time may an intermediary convert the electronic prescription to another form (e.g., facsimile) for transmission 42
43 EPCS Prescriber Requirements Obtain and use a two factor authentication credential Something you have (token) Something you know (password, PIN) Something you are (biometric) Ensures prescription integrity and non-repudiation Use a certified application (software) that records, stores and transmits information required under Sections 1311 and 1306 of 21 CFR Safeguard credentials 43
44 Electronic Prescribing Exceptions Technological or electrical failure; Use of EPCS would impact the patient s medical condition (up to 5 day supply); Issued by a practitioner to be dispensed outside of New York State; Federal Departments that do not fall under NY jurisdiction Veterinarians; Practitioners who have received a waiver from the Department of Health. 44
45 Electronic Prescribing Waivers Practitioners may apply for a waiver from the requirement to electronically prescribe controlled substances. Waivers will be granted upon a proper showing of economic hardship, technological limitations outside of the practitioner s control or other exceptional circumstances. By statute, waivers are good for one year, after which a practitioner may apply for a renewal. 45
46 Electronic Prescribing of Controlled Substance (ECPS) Pharmacy Responsibilities
47 Official Prescription Program NY issues forge-proof official prescription forms to all registered practitioners within the State Over 147,620,300 forms issued in 2012 Over 141,289,600 issued in 2013 At a cost of $78.7 M
48 EPCS Pharmacy Application Requirements Must meet DEA s requirements May only process controlled substance prescriptions using a certified pharmacy application Application must be able to set access controls Application must be able to import, store and display prescription requirements and verify the practitioner s digital signature Application must allow for pharmacist annotations and be maintained electronically
49 EPCS Take Aways Permissive now--mandated for ALL prescriptions March 27, 2015 Practitioners and pharmacists are required to use a certified application Certified application must be registered with BNE If the prescription starts electronically, it remains electronic Fax does not equate to electronic
50 What s Next Ensure that your software meets federal security requirements and that you are submitting controlled substance data to BNE in ASAP 4.2 standard Ensure that your certified software is registered with BNE Check BNE s website often for more information Prepare for a new work flow with the increase in Electronic prescriptions 50
51 New York State Laws and Pharmacy Where are we? What does it mean to Pharmacy? What do we do now? Elizabeth Lasky Capital Affairs, PSSNY Lobbyist
52 2014 Legislative Session Recap Part One: New Laws Bills that passed and what the new laws mean to practicing pharmacists Part Two PSSNY Priority Bills Recap and Update Part Three Additional Bills of Interest
53 2014 Legislative Session Recap Part One: New Laws Bills that passed and what the new laws mean to practicing pharmacists
54 2014 Legislative Session Recap New Law Consent for Delivery - A8612 A McDonald/S6449-A Hannon Requires registered pharmacies to contact the patient/caregiver before delivering prescriptions off-premises. Consent means 1. Signature upon delivery OR 2. Documented contact in the pharmacy s records OR 3. Opt-in program patient consent program updated every six months Pharmacies that deliver prescriptions without patient consent must 1. Accept medications that are returned 2. Credit patients for the co-pay Consent for delivery does not conflict with adherence programs, refill reminder programs and it does not apply to long term care.
55 2014 Legislative Session Recap New Law Vaccine Registry A9561-A Paulin/S7253 Hannon Gives pharmacists access to NYS and NYC children and adult registries Requires pharmacists and nurses to report immunizations to NYC or NYS registry with patient consent PSSNY s concerns 1. Excessive reporting requirements 2. Registries are not accurate unless reporting is mandatory for all
56 2014 Legislative Session Recap New Law CDTM extender - A9715 Glick/S7435 Hannon Moves the sunset from September 14, 2014 to September 14, 2015 Collaboration between a physician and a pharmacist
57 2014 Legislative Session Recap New Law Heroin response: Naloxone A8637-B Dinowitz/S6477-B Hannon Amends NYS Controlled Substances law allowing pharmacists to dispense naloxone/opioid antagonists with a prescription or non-patient specific order Requires Health Department to collect data and issue annual reports If non-patient specific order, pharmacist must document name of prescriber, name of opioid antagonist, date and name of person who received the medication For BNE updates check PSSNY E-scripts (available on line)
58 2014 Legislative Session Recap New Law Heroin Response: Criminalizes Not-In-Good-Faith Sale of Controlled Substances by Pharmacists and Practitioners S7902 Hannon/A10154 Rules (Governor s Program Bill) Class C felony Heroin Response: Adds Misrepresentation as a Pharmacist to Fraud and Deceit used to unlawfully obtain a controlled substance S7907 Marcellino/A10155 Rules (Governor s Program Bill) Class A Misdemeanor
59 2014 Legislative Session Recap New Law Mandatory insurance coverage for ostomy supplies A8137-A Magnarelli/S5937-A Valesky Mandates insurance coverage for ostomy supplies
60 2014 Legislative Session Recap New Law Safe Disposal: Requires Office of Alcoholism & Substance Abuse Services and Department of Environmental Conservation to publicize collection events and issue guidance A1609 Cymbrowitz/S6691 Boyle Guidelines issued August 14, 2014 with requirements for conducting household pharmaceutical collection events. (PSSNY E-Scripts August 28, 2014)
61 2014 Legislative Session Recap New Law Safe Disposal: Department of Environmental Conservation Demonstration Program A5465-A Sweeney/S3985-A Grisanti At least three disposal sites in State Police facilities Urban, Suburban, Rural DEC must promote safe disposal practices
62 2014 Legislative Session Recap New Law Medical Marijuana A6357-E Gottfried/S7923 Savino Authorizes NYS Health Department to register no more than five for-profit and not-for-profit geographically distributed organizations that are created for the purpose of acquiring, possessing, manufacturing, selling, delivering, transporting, distributing or dispensing marijuana for certified medical use to DOH-certified patients. DOH will set prices and establish excise tax Medical marijuana cannot be lawfully dispensed by a licensed pharmacist Sunsets in 7 years. Governor can stop the program at any time.
63 PSSNY PRIORITY LEGISLATION FOR 2015 Part Two PSSNY Priority Bills Recap and Update AMMO Reform MAC Appeal Scope of Practice 1. Expand and Reform Immunizer Law 2. Expand CDTM 3. Authorize pharmacists to perform CLIA-waived test
64 PSSNY PRIORITY LEGISLATION FOR 2015 Anti-Mandatory Mail Order A 5723-B Heastie/S 3995-B Maziarz Defines mail order pharmacy in Insurance Law Levels the playing field between community and mail order pharmacies Removes terms and conditions barrier imposed by PBMs Defines same reimbursement (same benchmark index, same NDC)
65 PSSNY PRIORITY LEGISLATION FOR 2015 Generic Fair Pricing MAC Appeals A9264-A Rosenthal/S7025-A Hannon Defines pharmacy benefit manager Amends Public Health Law (not Insurance Law) Requires PBM contracts to include a reasonable process to appeal, investigate and resolve disputes regarding multi-source generic drug pricing Right to appeal is limited to 60 days from filing original claim Requires PBMs to respond within 7 business days Successful appeals will apply retroactively to all similarly situated pharmacies Denials must document product is available at or below MAC
66 PSSNY PRIORITY LEGISLATION FOR 2015 Immunizer Expansion and Reform A9211-A Paulin/ S5688-A Hannon Removes sunsets (March 31, 2016 for flu, pneumo, meningococcal and July 1, 2015 for Zoster) NYS Health Department Program Bill Removes county restriction for non-patient specific orders Adds Tdap Retains adults-only For all vaccines, both patient-specific and non-patient-specific orders Allows NYS Commissioner of Health to issue statewide orders
67 PSSNY PRIORITY LEGISLATION FOR 2015 CDTM A7521 McDonald Allows CDTM by certified pharmacists in any setting Written collaborative agreement with a physician, nurse practitioner, physician assistant, facility or practice Certification requirements must meet two of the following 1. board certified by a national accrediting body acceptable to SED 2. accredited post-graduate residency with at least 50% direct patient care 3. documented experience providing clinical services to patients for 1,000 hours
68 PSSNY PRIORITY LEGISLATION FOR 2015 CLIA-Waived Tests Legislation is being researched and drafted Conducted with patient consent Screenings, upon request, including sub-emergent conditions Adjunct to ongoing medication therapy, results sent to primary care provider designated by the patient
69 Additional Bills of Interest Part Three Additional Bills of Interest
70 Additional Bills of Interest Medication Synchronization Facilitates synchronization of prescription refills (same day each month) Amends insurance law to require insurers to cover short fills Full dispensing fee for short fills Requires co-pay to be pro-rated National initiative
71 Additional Bills of Interest Require SP in out of state pharmacies to have NYS license LaValle/Glick Fills loophole in existing law (Out-of-state pharmacies must follow NYS controlled substances laws without knowing what they are) PBM Transparency Gottfried Defines PBMs as fiduciaries
72 Additional Bills of Interest Limited Services Clinics in pharmacies To be regulated by NYS Public Health Council For treatment of minor traumas not reasonably likely to be life-threatening For acute episodic illness or condition For episodic preventive treatment and services, i.e. immunization
73 What do we do now? Know your legislators. Relationships are VERY important. Stay informed with PSSNY s Weekly E-Script Support Pharmacy s Political Action Committee Educate others
74 Tracy Russell, CAE Executive Director Elizabeth Lasky Capital Affairs/Lobbyist
Electronic Prescribing In New York State
Electronic Prescribing In New York State Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 Overview Review the problem & e-prescribing mandate Describe
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: October 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
E-Prescribing of Controlled Substances (EPCS) New York State Board for Podiatry
E-Prescribing of Controlled Substances (EPCS) As of March 27, 2015 it will be mandatory for practitioners, excluding veterinarians, to issue electronic prescriptions for controlled and non-controlled substances.
FREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION
FREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION for the Revised: July 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
FREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is
Electronic Prescribing of Controlled Substances
Electronic Prescribing of Controlled Substances (EPCS) This document, as well as the software described in it, is provided under a software license agreement with STI Computer Services, Inc. Use of this
SUBMITTER S GUIDE TO ELECTRONIC DATA TRANSMISSION
SUBMITTER S GUIDE TO ELECTRONIC DATA TRANSMISSION for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
California State Board of Pharmacy and Medical Board of California
California State Board of Pharmacy and Medical Board of California Transmission and Receipt of Electronic Controlled Substance Prescriptions Pursuant to DEA Interim Final Rule (IFR): Electronic Prescriptions
How do I work with my pharmacy management system vendor to enable my pharmacy for e-prescribing via the Surescripts network?
Table of Contents How do I work with my pharmacy management system vendor to enable my pharmacy for e-prescribing via the Surescripts network?...1 Why should I report issues directly through my pharmacy
RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL
RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: October 13, 2014 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 Fax: 866-282-7076 [email protected]
Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances
American Society of Health-System Pharmacists 7272 Wisconsin Avenue Bethesda, Maryland 20814 (301) 657-3000 Fax: (301) 664-8877 www.ashp.org Drug Enforcement Administration Attention: DEA Federal Register
Why should I report issues directly through my pharmacy management system vendor and not Surescripts?
E-Prescribing FAQ Table of Contents p.4 How do I work with my pharmacy management system vendor to enable my pharmacy for e-prescribing via the Surescripts network? Why should I report issues directly
DEA's New Proposed Regulations For E-Prescribing
Portfolio Media, Inc. 648 Broadway, Suite 200 New York, NY 10012 www.law360.com Phone: +1 212 537 6331 Fax: +1 212 537 6371 [email protected] DEA's New Proposed Regulations For E-Prescribing
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
Manual of Instructions
NEW YORK STATE DEPARTMENT OF HEALTH OFFICIAL NEW YORK STATE PRESCRIPTION PROGRAM ELECTRONIC DATA TRANSMISSION Manual of Instructions New York State Department of Health Bureau of Narcotic Enforcement 433
Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014
MA PMP Pharmacy Data Entry and Data Submitter s FAQ Utilizing ASAP 4.2 Supplement to the MA PMP Pharmacy Data Entry and Data Submitter s Guide Utilizing ASAP 4.2 Massachusetts Department of Public Health
PRESCRIPTION MONITORING PROGRAM (PMP)
PRESCRIPTION MONITORING PROGRAM (PMP) DATA REPORTING MANUAL Effective Date: April 1, 2012 Contact Information: (505) 222-9830 [email protected] 1 P a g e Table of Contents Reporting requirements
SCOPE OF PRACTICE FOR ARNPS
FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow
Electronic Signature Guidance
National Council for Prescription Drug Programs White Paper Electronic Signature Guidance Version 1.0 February 2014 This document provides clarification and guidance to the industry for the use of electronic
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
NOTICES OF PROPOSED RULEMAKING
NOTICES OF PROPOSED RULEMAKING Unless exempted by A.R.S. 41-1005, each agency shall begin the rulemaking process by first submitting to the Secretary of State s Office a Notice of Rulemaking Docket Opening
New Jersey State Legislative Update. Opioid Addiction and Abuse Prevention. Legislative Package Moves Forward
New Jersey State Legislative Update Opioid Addiction and Abuse Prevention Legislative Package Moves Forward By Laurie A. Clark NJSIPP Legislative Counsel May 12, 2015 The New Jersey Legislature is currently
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
How To Check If A Prescription Is Filled In An Azarama
ARIZONA CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: January 1, 2015 Optimum Technology, Inc. 100 E. Campus View Blvd, Suite 380, Columbus, OH 43235 Contact
Drug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
11/26/2012. Implementation of Florida s PDMP. Disclosure
Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or
CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:
CHAPTER 74 AN ACT concerning drug abuse, revising various parts of the statutory law, and supplementing P.L.2007, c.244. BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 1.
NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP)
NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP) DATA COLLECTION MANUAL Effective Date: January 1, 2015 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 [email protected] Fax: 866-282-7076
Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
I-STOP: What You Need to Know. Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013
I-STOP: What You Need to Know Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013 What is I-STOP? Objectives Why is I-STOP necessary and how is it relevant
2014 New York State Legislative Session Summary of Pharmacy Legislation (Status at the end of the 2014 Session)
2014 New York State Legislative Session Summary of Pharmacy Legislation (Status at the end of the 2014 Session) CDTM Expansion A7521-A McDonald No same as SUMM : Amd 6801-a, Ed L; amd 5, Chap 21 of 2011,
Implementation of Florida s PDMP. Rebecca Poston Program Manager
Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:
PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.
PLEASE READ The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.us/ New Jersey Statutes Annotated (N.J.S.A.), published by
What Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
DC DEPARTMENT OF HEALTH Pharmaceutical Procurement and Distribution Pharmaceutical Warehouse. DC Health Care Safety Net ALLIANCE PROGRAM
DC DEPARTMENT OF HEALTH Pharmaceutical Warehouse DC Health Care Safety Net ALLIANCE PROGRAM OPERATIONAL PROTOCOLS Operational protocols for the DC Health Care Alliance program through the DOH Pharmaceutical
RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions
A Planning Guide for Electronic Prescriptions for Controlled Substances (EPCS)
A Planning Guide for Electronic Prescriptions for Controlled Substances (EPCS) The Federal Drug Enforcement Administration (DEA) regulates prescriptions of controlled substances that have risks for abuse.
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE April 8, 2011 EFFECTIVE DATE April 8, 2011 MEDICAL ASSISTANCE BULLETIN NUMBER 03-11-01, 09-11-02, 14-11-01, 18-11-01 24-11-03, 27-11-02, 31-11-02, 33-11-02 SUBJECT Electronic Prescribing Internet-based
Alaska Prescription Drug Monitoring Program
Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this
Minimum Performance and Service Criteria for Medicare Part D
Minimum Performance and Service Criteria for Medicare Part D 1. Terms and Conditions. In addition to the other terms and conditions of the Pharmacy Participation Agreement ( Agreement ), the following
BEYOND IDENTITY PROOFING: How EHRs Can Become More Than Just Vendors
BEYOND IDENTITY PROOFING: How EHRs Can Become More Than Just Vendors INTRODUCTION The implementation of electronic prescribing, or e-prescribing, is one of the most the groundbreaking changes in healthcare.
LAWS THAT PROVIDE REGULATION OF THE BUSINESS PRACTICES OF PHARMACY BENEFIT MANAGERS
LAWS THAT PROVIDE REGULATION OF THE BUSINESS PRACTICES OF PHARMACY BENEFIT MANAGERS ARKANSAS Title 17, Chapter 92 Section 17-92-1201, et.seq. Pharmacy Audit Bill of Rights sets forth standards for audits
Table of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4
Table of Contents User Request for Access... 3 User Login... 3 Upload a Data File... 4 Add Patient Records Direct Dispenser Users... 5 Pharmacy... 8 Search for Patient Records... 10 Search for Error Records...
May 21, 2010. Docket No. DEA-218. Dear Drug Enforcement Administration;
May 21, 2010 Drug Enforcement Administration Attention: DEA Federal Register Representative/ODL 8701 Morrissette Drive Springfield, VA 22152 [email protected] Re: Docket No. DEA-218 Dear Drug
Federal Regulations For Prescribing Scheduled Controlled Substances
Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system
EMR DOCUMENTATION LYNX. Instructor Script
EMR DOCUMENTATION LYNX Instructor Script Table of Contents TABLE OF CONTENTS INFORMATION SECURITY AND CONFIDENTIALITY... 4 OVERVIEW... 5 LEARNING OBJECTIVES... 5 TIPS AND TRICKS... 5 SOLUTION ICONS...
SAML for EPCS (Electronic Prescription of Controlled Substances)
SAML for EPCS (Electronic Prescription of Controlled Substances) Discussion Slides for review in the OASIS Security Services (SAML) TC August, 2014 DEA Regulation Compliance with New York s istop law-
Senate Bill No. 1665 CHAPTER 864
Senate Bill No. 1665 CHAPTER 864 An act to amend Section 2060 of, and to add Section 2290.5 to, the Business and Professions Code, to amend Sections 1367 and 1375.1 of, and to add Sections 1374.13 and
Pharmacy Operating Guidelines & Information
Pharmacy Operating Guidelines & Information RxAMERICA PHARMACY BENEFIT MANAGEMENT Pharmacy Operating Guidelines & Information Table of Contents I. Quick Reference List...3 C. D. E. Important Phone Numbers...
LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature First Regular Session - 2015 IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO.
LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature First Regular Session - IN THE HOUSE OF REPRESENTATIVES HOUSE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 AN ACT RELATING TO PHARMACIES; AMENDING
Prescribers required to check PDMP before first prescription for Controled Substances for new patient.
State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,
12 LC 33 4683S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT
The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 12 13 To amend Chapter 34 of Title 43 of the Official Code
Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014
Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Jeanne Tuttle, R.Ph. National Pharmacist Program Managers Pharmacy Benefits Management Services
Washington. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington
Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Idaho Board of Pharmacy Pharmacy Board http://idaho.pmpaware.net [email protected] Anderson, Teresa - Program Information Coordinator
LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322
LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - IN THE SENATE SENATE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 0 AN ACT RELATING TO EPINEPHRINE AUTO-INJECTORS; AMENDING
NCPDP Electronic Prescribing Standards
NCPDP Electronic Prescribing Standards September 2014 1 What is NCPDP? An ANSI-accredited standards development organization. Provides a forum and marketplace for a diverse membership focused on health
Advancements in Technology to Streamline and Expedite Patient Access. CBI Reimbursement & Access AUG 13, 2015 @ 2:15PM
Advancements in Technology to Streamline and Expedite Patient Access CBI Reimbursement & Access AUG 13, 2015 @ 2:15PM Learning Objectives Assess the current and future landscape as it relates to erx Understand
Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Jackson, Kate - PDMP Manager 55 Wade Ave Catonsville MD 21228 Office: (410) 402-8609 Fax: (410) 402-8601 Email: Maryland Department
E-Signature. The Pharmacy Perspective
E-Signature The Pharmacy Perspective Prescriptions arrive at a pharmacy today... Written by a prescriber ( not always on a prescription pad). Do not always know the prescriber s s handwriting legibility
2014 Legislative Session. Florida Pharmacy Laws(Statutes) Disclosure. Objectives. 465.014 (1) Pharmacy Technician. Pharmacy Law Update 4/22/2014
2014 Legislative Session Pharmacy Law Update George Malone, PharmD Chair, FSHP Legal & Regulatory Affairs Council HB 323/SB 278 HB 7077/SB 662 HB 859/SB 962 SB 7016 HQS1 Relating to Pharmacy Technicians
SASKATCHEWAN COLLEGE OF PHARMACISTS Electronic Transmission of Prescriptions. Policy Statement and Guidelines for Pharmacists
SASKATCHEWAN COLLEGE OF PHARMACISTS Electronic Transmission of Prescriptions PREAMBLE This document replaces the Operational Guidelines - Facsimile Transmission of Prescriptions Current legislation allows
Medicare Compliance and Fraud, Waste, and Abuse Training
Medicare Compliance and Fraud, Waste, and Abuse Training Objectives Recognize laws and concepts affecting compliance and fraud, waste, and abuse (FWA) Increase awareness of FWA Use identification techniques
e -Prescribing An Information Brief
e -Prescribing An Information Brief Prepared by: Maryland Health Care Commission June 2008 Introduction Technology creates efficiencies and opportunities in almost every industry, and health care is no
Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Higgins, Ronnie - Special Agent 40 Pryor St SW, Ste 2000 Atlanta GA 30303 Office: (404) 656-5100 Fax: (404) 651-8210 Email: [email protected]
CURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)
GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;
PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R047-15. September 15, 2015
PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY LCB File No. R047-15 September 15, 2015 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY:
"Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities" Before the Senate Judiciary Committee
DEA Congressional Testimony December 4, 2007 Statement of Joseph T. Rannazzisi Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration "Electronic Prescribing of Controlled
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,
A Practical Guide to Electronic Prescribing, Edition 2
A Practical Guide to Electronic Prescribing, Edition 2 FEBRUARY 2015 ESTABLISHED 2004 http://www.health.state.mn.us/e-health/ [email protected] Guide 3 Edition 2, issued February 2015 Edition 1, issued
Table of Contents. 2 P a g e
Table of Contents Introduction... 3 Important Contact Information... 3 Pharmacy Rights... 3 Claims Adjudication... 3 Reversals... 4 Required Data Fields... 4 Identification cards... 4 Required Identification
Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System
0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill
HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 371 CS Cancer Drug Donation Program SPONSOR(S): Harrell TIED BILLS: IDEN./SIM. BILLS: SB 1310 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care General
